🇺🇸 FDA
Patent

US 10561744

Multi-encapsulated formulations made with oxidized cellulose

granted A61KA61K31/282A61K31/445

Quick answer

US patent 10561744 (Multi-encapsulated formulations made with oxidized cellulose) held by Covidien LP expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Covidien LP
Grant date
Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/282, A61K31/445, A61K31/714, A61K49/00